ATE246929T1 - Wirkungen auf der endothelauskleidung und behandlung von vasospastischen erkrankungen - Google Patents
Wirkungen auf der endothelauskleidung und behandlung von vasospastischen erkrankungenInfo
- Publication number
- ATE246929T1 ATE246929T1 AT96911890T AT96911890T ATE246929T1 AT E246929 T1 ATE246929 T1 AT E246929T1 AT 96911890 T AT96911890 T AT 96911890T AT 96911890 T AT96911890 T AT 96911890T AT E246929 T1 ATE246929 T1 AT E246929T1
- Authority
- AT
- Austria
- Prior art keywords
- patient
- effects
- treatment
- endothelial lining
- vasospastic diseases
- Prior art date
Links
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 2
- 230000002455 vasospastic effect Effects 0.000 title abstract 2
- 201000010099 disease Diseases 0.000 title 1
- 230000000694 effects Effects 0.000 title 1
- 230000003511 endothelial effect Effects 0.000 title 1
- 210000004369 blood Anatomy 0.000 abstract 2
- 239000008280 blood Substances 0.000 abstract 2
- 101001057504 Homo sapiens Interferon-stimulated gene 20 kDa protein Proteins 0.000 abstract 1
- 101001055144 Homo sapiens Interleukin-2 receptor subunit alpha Proteins 0.000 abstract 1
- 102100026878 Interleukin-2 receptor subunit alpha Human genes 0.000 abstract 1
- 208000012322 Raynaud phenomenon Diseases 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 230000008753 endothelial function Effects 0.000 abstract 1
- 210000000265 leukocyte Anatomy 0.000 abstract 1
- 230000001590 oxidative effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/40—Peroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Virology (AREA)
- Inorganic Chemistry (AREA)
- Cardiology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Zoology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9509197.1A GB9509197D0 (en) | 1995-05-05 | 1995-05-05 | Endothelial lining effects |
| GBGB9522475.4A GB9522475D0 (en) | 1995-11-02 | 1995-11-02 | Treatment of raynauds phenomenon |
| PCT/CA1996/000282 WO1996034613A1 (en) | 1995-05-05 | 1996-05-03 | Endothelial lining effects and treatment of vasospastic disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE246929T1 true ATE246929T1 (de) | 2003-08-15 |
Family
ID=26306991
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT96911890T ATE246929T1 (de) | 1995-05-05 | 1996-05-03 | Wirkungen auf der endothelauskleidung und behandlung von vasospastischen erkrankungen |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP0768886B1 (de) |
| JP (1) | JPH10506636A (de) |
| AT (1) | ATE246929T1 (de) |
| AU (1) | AU721530B2 (de) |
| CA (1) | CA2194485C (de) |
| DE (1) | DE69629436T2 (de) |
| DK (1) | DK0768886T3 (de) |
| ES (1) | ES2205026T3 (de) |
| NZ (1) | NZ306395A (de) |
| PT (1) | PT768886E (de) |
| WO (1) | WO1996034613A1 (de) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6669965B2 (en) | 1992-02-07 | 2003-12-30 | Vasogen Ireland Limited | Method of treating atherosclerosis |
| US5980954A (en) | 1992-02-07 | 1999-11-09 | Vasogen Ireland Limited | Treatment of autoimmune diseases |
| CA2206180A1 (en) * | 1997-05-27 | 1998-11-27 | Vasogen Inc. | Treatment of chronic post-traumatic pain syndromes |
| PT1011696E (pt) * | 1997-09-12 | 2004-03-31 | Vasogen Ireland Ltd | Tratamento do stresse e precondicoes contra o stresse |
| US6432399B1 (en) | 1997-09-12 | 2002-08-13 | Vasogen Ireland Limited | Treatment of stress and preconditioning against stress |
| US6264646B1 (en) | 1998-11-13 | 2001-07-24 | Vasogen Ireland Limited | Method for preventing and reversing atherosclerosis in mammals |
| CA2360268A1 (en) * | 1999-01-12 | 2000-07-20 | Vasogen Ireland Limited | Pre-conditioning against cell death |
| CA2271190A1 (en) * | 1999-05-06 | 2000-11-06 | Vasogen Ireland Limited | Improved method for treating mammals with modified mammalian blood |
| DE60009724T2 (de) * | 1999-09-16 | 2005-04-28 | Vasogen Ireland Ltd., Shannon | Vorrichtung zum beeinflussen des blutes eines säugetieres |
| EP1218017B1 (de) | 1999-09-24 | 2005-11-16 | Vasogen Ireland Limited | Zusammensetzung zur behandlung von atherosklerose, welche ein statin und ex-vivo behandeltes blut enthält |
| CA2309417A1 (en) | 2000-05-25 | 2001-11-25 | Anthony E. Bolton | Apoptotic entities for use in treatment of endothelium dysfunction disorders |
| US7122208B2 (en) | 2001-04-06 | 2006-10-17 | Vasogen Ireland Limited | Compositions containing apoptotic entities |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5100378A (en) * | 1989-06-09 | 1992-03-31 | Neorx Corporation | Enhancement of target cell localization of lymphoid cells |
| DK0680346T3 (da) * | 1992-02-07 | 2002-10-28 | Vasogen Inc | Fremgangsmåde til forøgelse af koncentrationen af nitrogenoxid i blod |
| AU3506293A (en) * | 1992-02-07 | 1993-09-03 | Anthony Ernest Bolton | Method of inhibiting the aggregation of blood platelets |
| WO1995020649A1 (en) * | 1994-01-27 | 1995-08-03 | Cellcor, Inc. | Ex vivo activation of immune cells |
-
1996
- 1996-05-03 ES ES96911890T patent/ES2205026T3/es not_active Expired - Lifetime
- 1996-05-03 NZ NZ306395A patent/NZ306395A/en unknown
- 1996-05-03 CA CA002194485A patent/CA2194485C/en not_active Expired - Fee Related
- 1996-05-03 WO PCT/CA1996/000282 patent/WO1996034613A1/en not_active Ceased
- 1996-05-03 PT PT96911890T patent/PT768886E/pt unknown
- 1996-05-03 AT AT96911890T patent/ATE246929T1/de not_active IP Right Cessation
- 1996-05-03 JP JP8532887A patent/JPH10506636A/ja active Pending
- 1996-05-03 EP EP96911890A patent/EP0768886B1/de not_active Expired - Lifetime
- 1996-05-03 DK DK96911890T patent/DK0768886T3/da active
- 1996-05-03 DE DE69629436T patent/DE69629436T2/de not_active Expired - Fee Related
- 1996-05-03 AU AU54944/96A patent/AU721530B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| DE69629436T2 (de) | 2004-06-17 |
| WO1996034613A1 (en) | 1996-11-07 |
| NZ306395A (en) | 2000-02-28 |
| PT768886E (pt) | 2003-12-31 |
| CA2194485C (en) | 2001-09-18 |
| DK0768886T3 (da) | 2003-12-01 |
| AU721530B2 (en) | 2000-07-06 |
| DE69629436D1 (de) | 2003-09-18 |
| JPH10506636A (ja) | 1998-06-30 |
| CA2194485A1 (en) | 1996-11-07 |
| ES2205026T3 (es) | 2004-05-01 |
| EP0768886A1 (de) | 1997-04-23 |
| EP0768886B1 (de) | 2003-08-13 |
| AU5494496A (en) | 1996-11-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Cho et al. | Hydrogen peroxide stimulates macrophage vascular endothelial growth factor release | |
| DE69721006D1 (de) | Verwendung des modifizierten eigenen blutes zur behandlung von autoimmunerkrankungen | |
| DE69333775D1 (de) | Synthetische katalytische freie radikalfänger, verwendbar als antioxidantien zur prävention und therapie von krankheiten | |
| ATE399553T1 (de) | Pharmazeutische zusammensetzungen mit dextromethorphan und chinidin zur behandlung von neurologischen erkrankungen | |
| ATE191506T1 (de) | Gentherapeutische behandlung von gefässerkrankungen durch einen zellspezifischen, zellzyklusabhängigen wirkstoff | |
| ES2080837T3 (es) | Tratamiento de estados y enfermedades. | |
| ATE209908T1 (de) | RADIKALFÄNGER (ßSPIN TRAPSß) ZUR BEHANDLUNG VON MIT OXIDATION VON LIPIDEN UND PROTEINEN VERBUNDENEN ERKRANKUNGEN | |
| DE69533040D1 (de) | Medikamente zur vorbeugung oder behandlung von vaskulären hämorrhagien | |
| DE69433818D1 (de) | Kombinierte wirkstoffe als methode zur gezielten wirkstoff-freisetzung | |
| DE69731652D1 (de) | Verfahren zur behandlung von endothelialen verletzungen | |
| NO974275D0 (no) | Fremgangsmåte for behandling av tumorer | |
| ATE246929T1 (de) | Wirkungen auf der endothelauskleidung und behandlung von vasospastischen erkrankungen | |
| ATE232396T1 (de) | Oxydiertes thymosin beta 4 | |
| DE3582439D1 (de) | Mittel zur behandlung von herzerkrankungen. | |
| DE69631478D1 (de) | Verwendung von vitamin d4-derivaten zur behandlung von hauterkrankungen | |
| DK0661987T3 (da) | Morphogeninduceret leverregeneration | |
| DE69634499D1 (de) | Verwendungsmethoden von einkernigen phagozyten zur förderung der axonalen regeneration | |
| DE60137146D1 (de) | Fusionszellen und zytokin-zusammensetzungen zur behandlung von krankheiten | |
| DK0841912T3 (da) | 2-Aminocarbonyl-1,2-bis-(methylsulfonyl)-1-(substituerede)-hydraziner med antitumor-virkning | |
| ATE81467T1 (de) | Immunosuppression bei der auf immunotoxin basierten behandlung von menschen. | |
| ES2068714T3 (es) | Derivados de pirimidina para aumentar la actividad antitumoral. | |
| ES2036526T3 (es) | Composiciones de interferon. | |
| NO801387L (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive morfantridin-derivater | |
| TR199901385T2 (xx) | Piperidin t�revleri. | |
| ATE309807T1 (de) | Zusammensetzung zur behandlung von atherosklerose,welche ein statin und ex-vivo behandeltes blut enthält |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 0768886 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |